GSK3B and cancer: These data, in line with the previous report [26], confirmed that downregulation of OLA1 in human cancer cells enhances tumor growth in vivo and this effect is associated with decreased intratumoral apoptosis, attenuated ISR, and hyperactive GSK3β.